Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol vs endoscopic band ligation for primary prevention of esophageal variceal bleeding in cirrhosis
2011-006208-11Phase 3Terminated
- Sponsor
- CAIBER
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of carvedilol in esophageal varices and Cirrhosis (2 arms), sponsored by CAIBER. Primary endpoint: Time to first variceal bleeding or death. Started Feb 2012; status: terminated.
02
Drugs
carvedilol
03
Conditions
esophageal varicesCirrhosis
Beyond the preview
Go deeper on 2011-006208-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006208-11.